![]() |
What is it? |
|
"Amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's
disease, is a progressive neurodegenerative disease that affects nerve
cells in the brain and the spinal cord. Motor neurons reach from the
brain to the spinal cord and from the spinal cord to the muscles
throughout the body. The progressive degeneration of the motor neurons
in ALS eventually lead to their death. When the motor neurons die, the
ability of the brain to initiate and control muscle movement is
lost...." This is a direct quote from the ALS Association. For more info, please visit: http://www.alsa.org |
riluzole (Rilutek ®): |
|
MOA: Glutamate antagonist. Riluzole extends survival
and/or time to tracheostomy. Recommended dose: 50 mg
q12h. No increased benefit can be expected from higher daily doses, but
adverse events are increased. Rilutek tablets should be taken at least
an hour before, or two hours after, a meal to avoid a food-related
decrease in bioavailability. [Supplied: 50 mg tablet] |
Disclaimer |
|
Listed dosages are for - Adult patients ONLY. PLEASE READ THE
DISCLAIMER CAREFULLY BEFORE
ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE
TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.
GlobalRPH does not directly or indirectly practice medicine or provide
medical services and therefore assumes no liability whatsoever of any
kind for the information and data accessed through the Service or for
any diagnosis or treatment made in reliance thereon. David F. McAuley, Pharm.D., R.Ph. GlobalRPh Inc. |
| Disclaimer Contact Us Privacy Policy Website Search | We comply with the HONcode standard for health trustworthy information: Verify here. Copyright © 2007 GlobalRPh Inc. |
![]() |
|
